Metformin has been shown to impede EMT via hedgehog (Hh), Wnt, and transforming growth factor beta (TGFβ) pathways in many cancers including breast, cervical and NSCLC cancers [208,209,210]. This evidence concerns the gene TGFB1 and cancer.